Basic info
Industry
biotechnology research
Sectors
In-Vitro Diagnostics
Biotechnology
Liquid Biopsy
Early Cancer Detection
Cancer Mutation Detection
Head and Neck Cancer Screening
CAR-T and Immuno therapy
Translational Genomics
Personalized Radiation Therapy
Whole Genome Sequencing
Precision Molecular Diagnostics
Colorectal Cancer Mutation Detection
CLIA Lab
XNA Technology
HPV mRNA Test
Genetics
Medical
NGS
Cervical Cancer Screening
SuperbDNA Technology
Precision Medicine
Date founded
2012
Funding rounds raised
Total raised
$45M
from 2 investors over 2 rounds
D
DiaCarta, Inc. raised $45M on February 12, 2018
Investors: Fortune Fountain Capital
D
DiaCarta, Inc. raised $8M on January 9, 2015
Investors: BioVeda China Fund